Literature DB >> 19395207

Blood kinetics of ethyl glucuronide and ethyl sulphate in heavy drinkers during alcohol detoxification.

Gudrun Høiseth1, Luca Morini, Aldo Polettini, Asbjørg Christophersen, Jørg Mørland.   

Abstract

Studies of ethyl glucuronide (EtG) blood kinetics have so far been performed on healthy volunteers with ingestion of low to moderate doses of ethanol. These data are not necessarily transferable to heavy drinkers where the consumed doses of ethanol are much higher. The aim of this study was to investigate the pharmacokinetics of EtG and ethyl sulphate (EtS) in blood in heavy drinkers after termination of alcohol ingestion. Sixteen patients from an alcohol withdrawal clinic were included directly after admission. Time of end of drinking, estimated daily intake of ethanol (EDI) and medical history were recorded. Three to five blood samples over 20-43 h were collected from each patient subsequent to admission. The median EDI was 172 g (range 60-564). The first sample was collected median 2.5 h after end of drinking (range 0.5-23.5). Two patients had levels of EtG and EtS below LOQ in all samples, the first collected 19.25 and 23.5 h after cessation of drinking, respectively. Of the remaining 14 patients, one subject, suffering from both renal and hepatic disease, showed concentrations of EtG and EtS substantially higher than the rest of the material. This patient's initial value of EtG was 17.9 mg/L and of EtS 5.9 mg/L, with terminal elimination half lives of 11.9 h for EtG and 12.5 h for EtS. Among the remaining 13 patients, the initial median values were 0.7 g/L (range 0-3.7) for ethanol, 1.7 mg/L (range 0.1-5.9) for EtG and 0.9 mg/L (range 0.1-1.9) for EtS. Elimination occurred with a median half-life of 3.3 h for EtG (range 2.6-4.3) and 3.6 h for EtS (range 2.7-5.4). In conclusion, elimination of EtG in heavy drinkers did not significantly differ from healthy volunteers, and EtS appeared to have similar elimination rate. In the present work, there was one exception to this, and we propose that this could be explained by the patient's renal disease, which would delay excretion of these conjugated metabolites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19395207     DOI: 10.1016/j.forsciint.2009.03.017

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  11 in total

1.  Ethyl glucuronide concentrations in beard hair after a single alcohol dose: evidence for incorporation in hair root.

Authors:  Johannes Schräder; Michael Rothe; Fritz Pragst
Journal:  Int J Legal Med       Date:  2012-07-08       Impact factor: 2.686

2.  Evaluation of biomarkers assessing regular alcohol consumption in an occupational setting.

Authors:  Sonja Kilo; Birgit Hofmann; Elisabeth Eckert; Thomas Göen; Hans Drexler
Journal:  Int Arch Occup Environ Health       Date:  2016-07-09       Impact factor: 3.015

3.  Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials.

Authors:  Peter I Jatlow; Ann Agro; Ran Wu; Haleh Nadim; Benjamin A Toll; Elizabeth Ralevski; Christine Nogueira; Julia Shi; James D Dziura; Ismene L Petrakis; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

4.  Assistance of ethyl glucuronide and ethyl sulfate in the interpretation of postmortem ethanol findings.

Authors:  Hege Krabseth; Jørg Mørland; Gudrun Høiseth
Journal:  Int J Legal Med       Date:  2014-06-17       Impact factor: 2.686

5.  Less glucuronidation of morphine in the presence of ethanol in vivo.

Authors:  Gudrun Høiseth; Jannike Mørch Andersen; Jørg Mørland
Journal:  Eur J Clin Pharmacol       Date:  2013-06-06       Impact factor: 2.953

6.  Pharmacokinetics of Phosphatidylethanol 16:0/20:4 in Human Blood After Alcohol Intake.

Authors:  Marisa Lopez-Cruzan; John D Roache; Nathalie Hill-Kapturczak; Tara E Karns-Wright; Donald M Dougherty; Jesus J Sanchez; Wouter Koek; Martin A Javors
Journal:  Alcohol Clin Exp Res       Date:  2018-08-26       Impact factor: 3.455

7.  IGF-I and IGFBP-3 before and after inpatient alcohol detoxification in alcohol-dependent subjects.

Authors:  Ioannis Ilias; Thomas Paparrigopoulos; Elias Tzavellas; Dimitris Karaiskos; Panagiotis Kontoleon; Ioannis Liappas
Journal:  Med Sci Monit       Date:  2011-10

8.  Secondary Analysis of a Randomized Clinical Trial of Naltrexone Among Women Living With HIV: Correlations Between Reductions in Self-Reported Alcohol Use and Changes in Phosphatidylethanol.

Authors:  Veronica L Richards; Ruba Sajdeya; Karina Villalba; Yan Wang; Vaughn Bryant; Babette Brumback; Kendall Bryant; Judith A Hahn; Robert L Cook
Journal:  Alcohol Clin Exp Res       Date:  2020-12-17       Impact factor: 3.455

9.  A wearable biochemical sensor for monitoring alcohol consumption lifestyle through Ethyl glucuronide (EtG) detection in human sweat.

Authors:  Anjan Panneer Selvam; Sriram Muthukumar; Vikramshankar Kamakoti; Shalini Prasad
Journal:  Sci Rep       Date:  2016-03-21       Impact factor: 4.379

10.  Value of Ethyl Glucuronide and Ethyl Sulfate in Serum as Biomarkers of Alcohol Consumption.

Authors:  Lekhansh Shukla; Priyamvada Sharma; Suhas Ganesha; Deepak Ghadigaonkar; Evan Thomas; Arun Kandasamy; Pratima Murthy; Vivek Benegal
Journal:  Indian J Psychol Med       Date:  2017 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.